Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Stoel

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Cardiology|August 30, 2014
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registryHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Cardiology|April 27, 2017
Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS TrialLiefke C van der Heijden, Marlies M Kok, Marije M Löwik, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2016
Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trialLiefke C van der Heijden, Marlies M Kok, Marije M Löwik, et al.
JACC. Cardiovascular Interventions|March 16, 2020
Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-IIIAriel Roguin, Rosaly A Buiten, Carine J M Doggen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA studyMarlies M Kok, Clemens von Birgelen, Ming Kai Lam, et al.
International Journal of Cardiology|May 27, 2018
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPTPaolo Zocca, Marlies M Kok, Liefke C van der Heijden, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 19, 2019
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes studyEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2014
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcomeHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 8, 2014
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trialMing Kai Lam, Kenneth Tandjung, Hanim Sen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 22, 2024
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trialsEline H Ploumen, Edimir Semedo, Carine J M Doggen, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Cardiology|August 30, 2014
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registryHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Cardiology|April 27, 2017
Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS TrialLiefke C van der Heijden, Marlies M Kok, Marije M Löwik, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2016
Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trialLiefke C van der Heijden, Marlies M Kok, Marije M Löwik, et al.
JACC. Cardiovascular Interventions|March 16, 2020
Proximal LAD Treated With Thin-Strut New-Generation Drug-Eluting Stents: A Patient-Level Pooled Analysis of TWENTE I-IIIAriel Roguin, Rosaly A Buiten, Carine J M Doggen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA studyMarlies M Kok, Clemens von Birgelen, Ming Kai Lam, et al.
International Journal of Cardiology|May 27, 2018
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPTPaolo Zocca, Marlies M Kok, Liefke C van der Heijden, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 19, 2019
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes studyEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 4, 2014
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcomeHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 8, 2014
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trialMing Kai Lam, Kenneth Tandjung, Hanim Sen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 22, 2024
Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trialsEline H Ploumen, Edimir Semedo, Carine J M Doggen, et al.
Pageof 7